The Federal Trade Commission has released new data on the last four years’ worth of horizontal merger activity. Analysts saw two major points from these reports: the majority of FTC investigations pertained to mergers that exceeded the threshold for market concentration, determined by the 2010 Horizontal Merger Guidelines; additionally, the FTC treated mergers differently depending on the industry. According to the analysis, there were higher instances of enforcement action within the pharmaceutical and chemical companies, as compared with the hospital, electronically-controlled devides, and branded consumer goods markets.
Featured News
Former DOJ Antitrust Lawyer Returns to Sullivan & Cromwell
Jul 27, 2026 by
CPI
Trip.com Accepts $765 Million Antitrust Penalty as China Concludes Monopoly Investigation
Jul 27, 2026 by
CPI
Google Seeks to Exclude EU DMA Decision From Evidence in UK Shopping Damages Trial
Jul 27, 2026 by
CPI
Judge Allows Beef Price-Fixing Class Action to Move Toward Trial
Jul 27, 2026 by
CPI
Japanese Banks Combine Ship Finance Operations to Form $12.8B Maritime Lending Platform
Jul 27, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes